Skip to main content
. 2020 Mar 18;10(4):627–636. doi: 10.1002/2211-5463.12824

Fig. 9.

Fig. 9

Effects of miR‐542‐5p on the proliferation of osteosarcoma cells. (A) The results of a CCK‐8 assay in U2OS cells transfected with miR‐NC (miR‐Negtive control) or miR‐542‐5p mimic. (B) The results of a CCK‐8 assay in U2OS cells transfected with miR‐NC inhibitor or miR‐542‐5p inhibitor. All results are repeated as the mean ± standard error of the mean and analyzed with Student’s t‐test. *P < 0.05.